newsfilter
← Latest News
Business Wire·

Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

  • Vistagen President & CEO Shawn Singh will participate in a fireside chat at the RBC Capital Markets Global Healthcare conference on Wednesday, May 20, 2026, at 2:35 p.m. Eastern Time.
  • The company will host one-on-one meetings during the conference, with a live webcast available via the Investors section of its website & an archived replay to follow.
  • Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company developing intranasal pherines that target nose-to-brain neurocircuitry without requiring blood absorption or brain uptake.
  • Vistagen's advanced pherine candidates include fasedienol for acute social anxiety disorder (U.S. Phase 3), itruvone for major depressive disorder, & refisolone for menopausal vasomotor symptoms.